Peer Review History
| Original SubmissionSeptember 8, 2024 |
|---|
|
PONE-D-24-36994The Effect of Progressive Relaxation Training on Pain Characteristics, Attack Frequency, Activity Self-Efficacy, and Pain-Related Disability in Women with Episodic Tension-Type Headache and Migraine: A Cohort StudyPLOS ONE Dear Dr. KARAKUS, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 15 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Ming Liu Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. At PRTC, please ask the authors to include an explanation for the retrospective CT registration and confirmation that all related CTs are registered, using send back in ITC desk notes. At RTC, please check the authors' response and ping me if the authors do not address this. 3. In the online submission form, you indicated that [Data available on request from the author (A.K.)]. All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval. Additional Editor Comments : There are some flaws in this paper. The authors should revise the paper according to the reviewers' comments carefully. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: No Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is a cohort study, assessing the effect of PRT on various outcomes in women who suffer from Episodic headache tension and migraines. These have been considered as two separate groups. In the introduction - can the authors state what the hypothesis is. I.e do you expect the PRT to be more effective in one group compared to the other? Or the hypothesis is that PRT is effective regardless of type of headaches. The main concern, is the authors do not give enough information about the design of the study. Two groups are potentially receiving the same intervention and the sample size calculated is based on detecting group differences. In a conventional RCT, the power calculation would be aimed at measuring the effect of the intervention compared with usual care. In this case its comparing between groups based on type disease which makes the design complex. As the current study design suggest you have two groups presenting with different headache types but receiving the same intervention- should the question be looking at within difference instead of between? Since the between differences do not really make sense and make interpretation difficult - Can the authors comment on this point. Line 122- Add the word This is a “Prospective” cohort study- as its clear that you collected data prospectively. Inclusion criteria, include women with diagnosed THH - did the authors consider whether this would include newly diagnosed as well as those women who have suffered with this condition for a long period of time. Unsure why authors have used the CONSORT checklist as this is not an RCT Can all descriptive statistics in the table include median summaries as well, since n=20 in each group is a small sample. Can the authors comment on the uneven distribution of education level between groups? The analysis included individuals who adhered to the intervention - can this be stated in the methods section. A note that there would be some impact in the interpretation, i.e is this generalisable for women who do not adhere to the PRT? Perhaps this reflects the real world i.e would this indicate people affected by the condition and able to undertake the PRT? Sample size calculation/information written in protocol is different to what is written in the paper - can this be made consistent. Sample size planned was 40, but flow diagram shown 44 and conveniently 4 excluded women to non-adherence - this looks like biased??? Reviewer #2: Title: The Effect of Progressive Relaxation Training on Pain Characteristics, Attack Frequency, Activity Self-Efficacy, and Pain-Related Disability in Women with Episodic Tension-Type Headache and Migraine: A Cohort Study Positive Aspects: Relevant Topic: The study addresses a highly relevant issue in public health and clinical practice. Primary headaches, such as migraines and episodic tension-type headaches (TTH), are highly prevalent, especially affecting young women. Investigating the effectiveness of progressive relaxation training (PRT) in improving key variables like pain intensity, attack frequency, and pain-related disability is important to promote non-pharmacological interventions. Appropriate Study Design: The manuscript presents a well-structured cohort design, with clearly defined outcome measures, such as the Visual Analog Scale (VAS), the Headache Impact Test (HIT-6), and the Pain Catastrophizing Scale (PCS). The PRT intervention was standardized, and the use of a comparison between migraine and tension-type headache groups strengthens the comparative analysis. Coherent and Relevant Results: The results show a significant reduction in the intensity and frequency of pain attacks in both groups, with notable improvements in perceived activity self-efficacy and pain-coping abilities. This demonstrates the clinical utility of PRT for populations suffering from headaches, which could encourage its implementation in routine treatments. Areas for Improvement: Lack of Blinding: A significant limitation of the study is the absence of blinding, as the researchers administering the intervention also conducted the assessments. This introduces potential bias, especially in studies involving subjective interventions such as PRT. It is suggested that future research includes blinded evaluators. Absence of a Placebo-Controlled Group: Although the study includes comparison groups (migraine and TTH), the lack of a placebo-controlled group limits the interpretation of results. A placebo group would have provided a more robust evaluation of the isolated effect of PRT on outcomes, reducing participant expectation bias. Generalization of Results: The study focused exclusively on young women with episodic headaches, limiting generalization to other populations, such as men or patients with chronic headaches. Future studies should broaden the sample to include a more diverse population and explore whether the effects of PRT are similar in other age groups and headache types. Detailing of Statistical Analysis Protocol: While the use of SPSS software was mentioned, it would be beneficial to include more details regarding the statistical tests applied, particularly in terms of multivariate analysis, corrections for multiple comparisons, and justifications for the sample size used. Suggestions for Improvement: Include a more robust section on the safety of the intervention, as muscle relaxation might impact musculoskeletal conditions. Explore in greater depth the physiological differences between migraine and TTH patients and how these differences relate to the study’s findings. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-24-36994R1The Comparative Effectiveness of Progressive Relaxation Training on Pain Characteristics, Attack Frequency, Activity Self-Efficacy, and Pain-Related Disability in Women with Episodic Tension-Type Headache and MigrainePLOS ONE Dear Dr. KARAKUS, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 02 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Ming Liu Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Please revise the paper carefully following the reviewers comments. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed Reviewer #4: All comments have been addressed Reviewer #5: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: Partly Reviewer #4: Partly Reviewer #5: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: No Reviewer #4: No Reviewer #5: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: (No Response) Reviewer #3: (No Response) Reviewer #4: Sincerely The study was statistically and methodologically reviewed. Please make the following corrections: The article is a clinical trial exploring the effectiveness of progressive relaxation training (PRT) in women with episodic tension-type headache (TTH) and migraine. Below are the identified flaws and areas for improvement: The lack of evaluator blinding introduces bias, especially in subjective assessments such as pain scales. The study does not include a placebo or alternative intervention group, which limits the robustness of the conclusions regarding the specific effects of PRT. While a post-hoc analysis showed sufficient power, the small sample size (n=20 per group) may affect the generalizability of results and could lead to an overestimation of effect sizes. Median summaries are not consistently provided despite the small sample size, which might skew the interpretation of results. The paper does not mention adjustments for multiple statistical tests, potentially inflating the risk of Type I errors. Limited details about multivariate analysis or rationale for specific tests reduce the clarity of the statistical approach. Inclusion of only women within a narrow age range (20–45 years) limits the applicability of findings to broader populations, including men and older individuals. The inclusion criteria (recent diagnoses for migraines and TTH) might not reflect chronic headache sufferers, a significant subgroup in clinical practice. The rationale for comparing outcomes between two different headache types, which inherently have different pathophysiological mechanisms, is unclear and complicates interpretation. The discussion lacks depth in explaining how PRT impacts the distinct mechanisms of migraine and TTH. Uneven distribution of education levels between groups is noted but not adequately discussed regarding its potential impact on outcomes. Although ethical approval is mentioned, additional details about how informed consent was obtained and adherence monitoring are absent. The exclusion of non-adherent participants raises questions about the intervention's feasibility and applicability in real-world settings. While safety measures are briefly described, a dedicated section detailing adverse effects or participant concerns during PRT sessions is missing. The inclusion of a CONSORT checklist for a non-RCT study is inappropriate and inconsistent. Incorporate a placebo or active comparator group in future studies. Ensure evaluator blinding to reduce bias. Expand the sample to include diverse demographic groups for better generalizability. Provide detailed explanations of statistical methods, particularly corrections for multiple testing. Address the uneven distribution of education levels and its implications for the findings. Include a robust discussion of PRT's mechanisms of action on migraine and TTH. Offer a clearer rationale for between-group comparisons and their relevance to clinical practice. Good luck. Reviewer #5: Good paper with enough information, but I did not find all details related to consort checklist. The method section has lots of missing points: like sample size, two group explanation, randomization and blinding process. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #2: No Reviewer #3: Yes: Dr Aman Suresh T Assistant Professor , Faculty of Pharmacy Dr MGR educational trust and research institute Reviewer #4: Yes: Ebrahim Abbasi Reviewer #5: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
The Comparative Effectiveness of Progressive Relaxation Training on Pain Characteristics, Attack Frequency, Activity Self-Efficacy, and Pain-Related Disability in Women with Episodic Tension-Type Headache and Migraine PONE-D-24-36994R2 Dear Dr. KARAKUS, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ming Liu Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #6: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #6: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #6: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #6: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #6: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: All comments have been addressed Reviewer #6: Dear author, Thank you for your nice work. You already incorporated all my comment and suggestion . I suggested for publication and keep it up the nice work to feed the world community. Once again congratulations for the interesting work. This is what is what is expected from us and let we play our responsibility as professional. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #6: No ********** |
| Formally Accepted |
|
PONE-D-24-36994R2 PLOS ONE Dear Dr. Karakus, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Ming Liu Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .